Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Bio-Rad Laboratories (BIO)

Bio-Rad Names Rajat Mehta EVP of Global Commercial Operations, Effective August 4

Neutral Impact 3 of 5 leadership Written later

Bio-Rad Laboratories appointed Rajat Mehta as Executive Vice President, Global Commercial Operations, effective August 4, 2025, succeeding Mike Crowley, who is retiring after a 26-year career with the company. Mehta previously served as Senior Vice President at Labcorp and as Vice President and General Manager at Thermo Fisher Scientific.

Key points

  • Rajat Mehta becomes EVP, Global Commercial Operations, effective August 4, 2025
  • Mike Crowley, who announced his retirement on January 31, 2025, will no longer be an executive officer and will remain an employee until September 2025 to assist with the transition
  • Mehta joins from Labcorp, where he was Senior Vice President overseeing commercial operations for the West Division

The filing

CompanyBio-Rad Laboratories (BIO)
Form8-K, current report
Filed with the SECJul 28, 2025, 4:14 PM ET
Accession number0000012208-25-000047

Items reported: 5.02 Director / Officer Change8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 28, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.